柴克瓦·纳尼·纳尔逊:克服癌症和博茨瓦纳领先的瘤学
Nandan M Shanbhag1,2, Sneha N Shanbhag3
1Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, ARE.
Cureus
|September 5, 2024
概括
瘤护士Chaikhwa Nani Nelson将她个人癌症的旅程转化为博茨瓦纳的以患者为中心的护理倡导. 她创立了全国第一个癌症支持小组,为患者和家人改善资源.
科学领域:
- 瘤科 护理 护理专业
- 癌症护理倡导 癌症护理倡导
- 患者支持系统 患者支持系统
背景情况:
- 查伊克瓦·纳尼·尼尔森 (Chaikhwa Nani Nelson) 在2013年被诊断患有骨髓瘤,接受了截肢和化疗.
- 个人逆境激发了对改善癌症患者体验的热情.
研究的目的:
- 突出个人经验对瘤护理的影响.
- 为了展示博茨瓦纳第一个癌症支持小组的建立.
- 倡导以患者为中心和富有同情心的癌症护理.
主要方法:
- 个人叙事和宣传努力.
- 创立并领导一个癌症支持小组.
- 在临床瘤学方面获得国际认可和高级教育.
主要成果:
- 为博茨瓦纳的癌症患者和家属建立了一个重要的社区资源.
- 提高对以患者为中心的瘤治疗的认识和倡导.
- 获得了领导力和国际赞誉,为癌症支持做出了贡献.
结论:
- 个人恢复力可以推动医疗保健的重大进步.
- 建立支持网络对于癌症患者的福祉至关重要.
- 查伊克瓦·纳尼·纳尔逊是博茨瓦纳瘤学领域的先驱领导者.
相关概念视频
Cancer
51.7K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
51.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Treatment Resistant Cancers
2.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.6K
Rous Sarcoma Virus (RSV) and Cancer
5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.2K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863


